Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split?

Eur Heart J. 2015 Apr 14;36(15):902-5. doi: 10.1093/eurheartj/ehv015. Epub 2015 Jan 29.
No abstract available

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Aminobutyrates / therapeutic use
  • Angiotensin Receptor Antagonists / therapeutic use
  • Animals
  • Biphenyl Compounds
  • Blood-Brain Barrier / drug effects
  • Cardiovascular Diseases / drug therapy*
  • Clinical Trials as Topic
  • Drug Combinations
  • Humans
  • Neprilysin / antagonists & inhibitors*
  • Tetrazoles / therapeutic use
  • Valsartan

Substances

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • Neprilysin
  • sacubitril and valsartan sodium hydrate drug combination